Physical activity in recurrent colon cancer: Cancer and Leukemia Group B/SWOG 80702 (Alliance)

Justin C. Brown, LSU Health Sciences Center - New Orleans
Chao Ma, Dana-Farber Cancer Institute
Qian Shi, Mayo Clinic
Tyler Zemla, Mayo Clinic
Felix Couture, CHU de Québec - Université Laval
Philip Kuebler, Columbus National Cancer Institute Community Oncology Research Program (NCORP)
Pankaj Kumar, Heartland Cancer Research National Cancer Institute Community Oncology Research Program
Benjamin Tan, Alvin J. Siteman Cancer Center
Smitha Krishnamurthi, Cleveland Clinic Foundation
Victor Chang, VA Medical Center
Richard M. Goldberg, West Virginia University
Alan P. Venook, University of California, San Francisco
Charles D. Blanke, Oregon Health & Science University
Eileen M. O’Reilly, Memorial Sloan-Kettering Cancer Center
Anthony F. Shields, Wayne State University
Jeffrey A. Meyerhardt, Dana-Farber Cancer Institute

Abstract

Background: One in three patients with stage III colon cancer will experience tumor recurrence. It is uncertain whether physical activity during and after postoperative chemotherapy for stage III colon cancer improves overall survival after tumor recurrence. Methods: A prospective cohort study nested within a randomized multicenter trial of patients initially diagnosed with stage III colon cancer who experienced tumor recurrence (N = 399) was conducted. Postoperative physical activity before tumor recurrence was measured. Physical activity energy expenditure was quantified via metabolic equivalent task hours per week (MET-h/week). The primary end point was overall survival after tumor recurrence. Multivariable flexible parametric survival models estimated relative and absolute effects with two-sided hypothesis tests. Results: Compared with patients expending <3.0 MET-h/week of physical activity (comparable to <1.0 h/week of brisk walking), patients with ≥18.0 MET-h/week of physical activity (comparable to 6 h/week of brisk walking) had a 33% relative improvement in overall survival time after tumor recurrence (hazard ratio, 0.67; 95% CI, 0.42–0.96). The overall survival rate at 3 years after tumor recurrence was 61.3% (95% CI, 51.8%–69.2%) with <3.0 MET-h/week of physical activity and 72.2% (95% CI, 63.1%–79.6%) with ≥18 MET-h/week of physical activity (risk difference, 10.9 percentage points; 95% CI, 1.2–20.8 percentage points). Conclusions: Higher postoperative physical activity is associated with improved overall survival after tumor recurrence in patients initially diagnosed with stage III colon cancer. These data may be relevant to patients who, despite optimal postoperative medical therapy, have a high risk of tumor recurrence.